Published in Aging Male on March 01, 2009
Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011. J Clin Endocrinol Metab (2014) 2.18
Reference Ranges and Association of Age and Lifestyle Characteristics with Testosterone, Sex Hormone Binding Globulin, and Luteinizing Hormone among 1166 Western Chinese Men. PLoS One (2016) 1.39
Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy. Int J Endocrinol (2012) 1.18
Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. Aging Male (2015) 0.97
Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss. Clin Obes (2013) 0.92
Oxidative stress, testosterone, and cognition among Caucasian and Mexican-American men with and without Alzheimer's disease. J Alzheimers Dis (2014) 0.81
Gonadal status and physical performance in older men. Aging Male (2010) 0.81
Elderly men over 65 years of age with late-onset hypogonadism benefit as much from testosterone treatment as do younger men. Korean J Urol (2015) 0.80
No effects of n-3 fatty acid supplementation on serum total testosterone levels in older men: the Alpha Omega Trial. Int J Androl (2012) 0.80
When is a varicocele repair indicated: the dilemma of hypogonadism and erectile dysfunction? Asian J Androl (2016) 0.80
Beneficial effects of testosterone therapy on functional capacity, cardiovascular parameters, and quality of life in patients with congestive heart failure. Biomed Res Int (2014) 0.80
A 6-month observational study of energy, sexual desire, and body proportions in hypogonadal men treated with a testosterone 1% gel. Aging Male (2013) 0.79
Relevance of low testosterone to non-alcoholic fatty liver disease. Cardiovasc Endocrinol (2015) 0.77
Testosterone deficiency and treatment in older men: definition, treatment, pitfalls. Asian J Androl (2010) 0.76
Dynamics of hormonal disorders following unilateral orchiectomy for a testicular tumor. Med Oncol (2017) 0.75
Increased sexual desire with exogenous testosterone administration in men with obstructive sleep apnea: a randomized placebo-controlled study. Andrology (2015) 0.75
The implications of low testosterone on mortality in men. Curr Sex Health Rep (2014) 0.75
Andropause - state of the art 2015 and review of selected aspects. Prz Menopauzalny (2015) 0.75
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA (2008) 13.35
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA (2011) 11.02
Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst (2013) 10.30
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2010) 7.15
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin (2010) 6.45
Intermittent versus continuous androgen deprivation in prostate cancer. N Engl J Med (2013) 6.17
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc (2011) 5.96
An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection. J Natl Cancer Inst (2011) 5.73
Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2006) 5.58
Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA (2013) 5.56
Cachexia: a new definition. Clin Nutr (2008) 5.49
Towards less confusing terminology in reproductive medicine: a proposal. Fertil Steril (2004) 4.76
Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial. J Natl Cancer Inst (2007) 4.64
Integrating the predictiveness of a marker with its performance as a classifier. Am J Epidemiol (2007) 4.59
Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci (2006) 4.25
Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2009) 4.04
Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev (2006) 4.02
Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach. Cancer Prev Res (Phila) (2008) 3.99
Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. J Am Med Dir Assoc (2012) 3.77
Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab (2004) 3.45
The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc (2012) 3.45
Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer. J Clin Oncol (2005) 3.22
Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab (2010) 3.15
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst (2005) 2.99
Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794. J Clin Oncol (2007) 2.97
Estimated impact of the Prostate Cancer Prevention Trial on population mortality. Cancer (2005) 2.91
Klinefelter's syndrome. Lancet (2004) 2.89
Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res (2004) 2.76
Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study. Clin Cancer Res (2013) 2.70
Managing persons with dementia in the nursing home: high touch trumps high tech. J Am Med Dir Assoc (2008) 2.58
Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 study. J Clin Oncol (2011) 2.57
Prospective evaluation of operating characteristics of prostate cancer detection biomarkers. J Urol (2010) 2.54
A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol (2013) 2.52
Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle. J Cachexia Sarcopenia Muscle (2010) 2.49
Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention. Cancer Prev Res (Phila) (2008) 2.43
Varicocele and male factor infertility treatment: a new meta-analysis and review of the role of varicocele repair. Eur Urol (2011) 2.41
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer. Clin Chem (2007) 2.38
A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness. Cancer Epidemiol Biomarkers Prev (2010) 2.36
Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab (2004) 2.35
Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes (2004) 2.33
Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes (2011) 2.29
Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial. Lancet Oncol (2013) 2.29
Clinical and diagnostic features of patients with suspected Klinefelter syndrome. J Androl (2003) 2.29
Association of hypogonadism with vitamin D status: the European Male Ageing Study. Eur J Endocrinol (2011) 2.28
A model for managing delirious older inpatients. J Am Geriatr Soc (2003) 2.27
The development of outpatient Clinical Glidepaths. J Am Geriatr Soc (2002) 2.26
Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. J Urol (2007) 2.24
Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial. J Urol (2005) 2.24
Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias. Clin Chem (2007) 2.23
Use of statins and outcome of BCG treatment for bladder cancer. N Engl J Med (2006) 2.23
Routine voiding cystourethrography is of no value in neonates with unilateral multicystic dysplastic kidney. J Pediatr (2005) 2.22
Appetite assessment: simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr (2005) 2.15
History of bacillus Calmette-Guerin and bladder cancer: an immunotherapy success story. J Urol (2007) 2.15
Understanding clinical dehydration and its treatment. J Am Med Dir Assoc (2008) 2.10
Pharmacological approaches to reducing the risk of prostate cancer. Eur Urol (2009) 2.09
Predicting risk of prostate cancer in men receiving finasteride: effect of prostate volume, number of biopsy cores, and American Urological Association symptom score. Urology (2013) 2.06
Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev (2009) 2.06
External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population. Urology (2006) 2.05
Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab (2010) 2.01
Hypogonadism, testosterone, and nursing home residents. J Am Med Dir Assoc (2013) 2.00
Effects of leptin on memory processing. Peptides (2005) 1.97
Tramadol HCL has promise in on-demand use to treat premature ejaculation. J Sex Med (2007) 1.96
Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc (2013) 1.96
Obesity and hypertriglyceridemia produce cognitive impairment. Endocrinology (2008) 1.94
The prostate cancer prevention trial: design, biases and interpretation of study results. J Urol (2006) 1.91
The benefits and risks of testosterone replacement therapy: a review. Ther Clin Risk Manag (2009) 1.90
Finasteride reduces the risk of incident clinical benign prostatic hyperplasia. Eur Urol (2012) 1.89
An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle (2010) 1.89
Acetylcholine and molecular components of its synthesis and release machinery in the urothelium. Eur Urol (2006) 1.89
Comparison of the Saint Louis University mental status examination and the mini-mental state examination for detecting dementia and mild neurocognitive disorder--a pilot study. Am J Geriatr Psychiatry (2006) 1.88
Limitations of basing screening policies on screening trials: The US Preventive Services Task Force and Prostate Cancer Screening. Med Care (2013) 1.88
Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. Eur Urol (2007) 1.82
Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care (2007) 1.82
Gene polymorphisms and male infertility--a meta-analysis and literature review. Reprod Biomed Online (2007) 1.79
Male hormonal contraception: a double-blind, placebo-controlled study. J Clin Endocrinol Metab (2008) 1.79
Clinically relevant levels of depressive symptoms in community-dwelling middle-aged African Americans. J Am Geriatr Soc (2004) 1.78
Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab (2006) 1.78
Summary of the recommendations on sexual dysfunctions in men. J Sex Med (2004) 1.78
Urine metabolomics analysis for kidney cancer detection and biomarker discovery. Mol Cell Proteomics (2008) 1.78
Editorial: Something about frailty. J Gerontol A Biol Sci Med Sci (2002) 1.75
Is there a standard of care for pathologic stage T3 prostate cancer? J Clin Oncol (2009) 1.73
Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol (2011) 1.71
Implementation of the Prostate Cancer Prevention Trial (PCPT). Control Clin Trials (2004) 1.70
Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. Eur Urol (2006) 1.70
Ten-year survival in patients with metastatic prostate cancer. Clin Prostate Cancer (2003) 1.70
Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy. J Clin Oncol (2008) 1.69
American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update. Endocr Pract (2004) 1.69
Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'OSteoporose) Study. Am J Clin Nutr (2009) 1.68
Validation in a multiple urology practice cohort of the Prostate Cancer Prevention Trial calculator for predicting prostate cancer detection. J Urol (2009) 1.68
The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem (2003) 1.67
Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk. J Natl Cancer Inst (2014) 1.67
A critical analysis of nonsurgical treatment of Peyronie's disease. Eur Urol (2006) 1.67
Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol (2008) 1.66
Anorexia and weight loss in older persons. J Gerontol A Biol Sci Med Sci (2003) 1.66
Mobility performance: a high-tech test for geriatricians. J Gerontol A Biol Sci Med Sci (2003) 1.66